BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $10,638,000 | +2.0% | 132,579 | +2.2% | 1.54% | -9.0% |
Q3 2020 | $10,429,000 | -7.8% | 129,693 | -1.3% | 1.69% | -12.1% |
Q2 2020 | $11,312,000 | +3.5% | 131,383 | -2.4% | 1.93% | -11.7% |
Q1 2020 | $10,925,000 | -10.6% | 134,569 | -8.0% | 2.18% | +14.7% |
Q4 2019 | $12,226,000 | -6.3% | 146,220 | -2.0% | 1.90% | -11.1% |
Q3 2019 | $13,044,000 | +5.1% | 149,130 | -1.6% | 2.14% | +2.6% |
Q2 2019 | $12,408,000 | -9.5% | 151,508 | -10.2% | 2.09% | -9.3% |
Q1 2019 | $13,710,000 | +31.9% | 168,625 | +6.8% | 2.30% | +11.2% |
Q4 2018 | $10,394,000 | -7.8% | 157,924 | +8.0% | 2.07% | -0.4% |
Q3 2018 | $11,271,000 | +2.9% | 146,212 | -1.4% | 2.08% | -0.4% |
Q2 2018 | $10,953,000 | +14.3% | 148,344 | +0.7% | 2.09% | +11.8% |
Q1 2018 | $9,582,000 | +3.6% | 147,331 | +2.9% | 1.87% | +4.8% |
Q4 2017 | $9,251,000 | +1.4% | 143,116 | -1.6% | 1.78% | +1.5% |
Q3 2017 | $9,123,000 | +0.8% | 145,400 | -2.7% | 1.76% | -0.8% |
Q2 2017 | $9,048,000 | +282.9% | 149,461 | +315.5% | 1.77% | +652.8% |
Q3 2013 | $2,363,000 | -18.6% | 35,975 | -14.2% | 0.24% | -21.1% |
Q2 2013 | $2,902,000 | – | 41,905 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |